Șandor, A.; Crișan, O.; Marc, G.; Fizeșan, I.; Ionuț, I.; Moldovan, C.; Stana, A.; Oniga, I.; Pîrnău, A.; Vlase, L.;
et al. Rational Design and Synthesis of a Novel Series of Thiosemicarbazone-Containing Quinazoline Derivatives as Potential VEGFR2 Inhibitors. Pharmaceutics 2025, 17, 260.
https://doi.org/10.3390/pharmaceutics17020260
AMA Style
Șandor A, Crișan O, Marc G, Fizeșan I, Ionuț I, Moldovan C, Stana A, Oniga I, Pîrnău A, Vlase L,
et al. Rational Design and Synthesis of a Novel Series of Thiosemicarbazone-Containing Quinazoline Derivatives as Potential VEGFR2 Inhibitors. Pharmaceutics. 2025; 17(2):260.
https://doi.org/10.3390/pharmaceutics17020260
Chicago/Turabian Style
Șandor, Alexandru, Ovidiu Crișan, Gabriel Marc, Ionel Fizeșan, Ioana Ionuț, Cristina Moldovan, Anca Stana, Ilioara Oniga, Adrian Pîrnău, Laurian Vlase,
and et al. 2025. "Rational Design and Synthesis of a Novel Series of Thiosemicarbazone-Containing Quinazoline Derivatives as Potential VEGFR2 Inhibitors" Pharmaceutics 17, no. 2: 260.
https://doi.org/10.3390/pharmaceutics17020260
APA Style
Șandor, A., Crișan, O., Marc, G., Fizeșan, I., Ionuț, I., Moldovan, C., Stana, A., Oniga, I., Pîrnău, A., Vlase, L., Petru, A.-E., Creștin, I.-V., Jîjie, A.-R., Tiperciuc, B., & Oniga, O.
(2025). Rational Design and Synthesis of a Novel Series of Thiosemicarbazone-Containing Quinazoline Derivatives as Potential VEGFR2 Inhibitors. Pharmaceutics, 17(2), 260.
https://doi.org/10.3390/pharmaceutics17020260
